Sarepta Therapeutics
(SRPT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 871,668 | 966,777 | 1,038,624 | 868,565 | 1,233,877 |
| Marketable Securities | 1,010,429 | 1,022,597 | 1,033,860 | 1,059,454 | 779,548 |
| Receivables | 223,836 | 214,628 | 201,509 | 203,854 | 178,194 |
| Inventories | 202,675 | 203,968 | 221,192 | 208,095 | 198,997 |
| Other current assets | 179,769 | 149,891 | 130,744 | 129,332 | 140,331 |
| TOTAL | $2,488,377 | $2,557,861 | $2,625,929 | $2,469,300 | $2,530,947 |
| Non-Current Assets | |||||
| PPE Net | 182,862 | 180,037 | 181,005 | 183,292 | 187,248 |
| Intangibles | 0 | 0 | 13,057 | 13,062 | 13,328 |
| Other Non-Current Assets | 388,547 | 390,468 | 336,158 | 331,199 | 324,631 |
| TOTAL | $571,409 | $570,505 | $530,220 | $527,553 | $525,207 |
| Total Assets | $3,059,786 | $3,128,366 | $3,156,149 | $2,996,853 | $3,056,154 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 106,710 | 95,875 | 118,461 | 56,207 | 54,007 |
| Accrued Expenses | 345,554 | 418,996 | 368,998 | 383,699 | 293,908 |
| Other current liabilities | 17,381 | N/A | 26,213 | 16,416 | 17,803 |
| TOTAL | $536,884 | $619,604 | $602,916 | $545,566 | $454,962 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,234,284 | 1,544,292 | 1,542,770 | 1,100,873 | 1,098,847 |
| Deferred Revenues | 67,239 | 89,244 | 89,244 | 89,244 | 89,244 |
| Other Non-Current Liabilities | 90,869 | 94,520 | 72,129 | 93,968 | 93,220 |
| TOTAL | $1,810,153 | $2,123,812 | $2,122,393 | $1,724,830 | $1,744,306 |
| Total Liabilities | $2,347,037 | $2,743,416 | $2,725,309 | $2,270,396 | $2,199,268 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 93,149 | 87,982 | 87,783 | 87,568 | 87,501 |
| Common Shares | 9 | 9 | 9 | 9 | 9 |
| Retained earnings | -4,426,991 | -3,910,236 | -3,800,992 | -3,543,254 | -3,311,773 |
| Other shareholders' equity | -419 | -1,664 | -3,205 | -2,485 | -306 |
| TOTAL | $712,749 | $384,950 | $430,840 | $726,457 | $856,886 |
| Total Liabilities And Equity | $3,059,786 | $3,128,366 | $3,156,149 | $2,996,853 | $3,056,154 |